H1N1流感病毒肺炎患者ARDS的核磁共振代谢组学特征
本研究用核磁共振(NMR)光谱分析30例H1N1流感病毒肺炎患者(推导集)的血清代谢组,以无监督主成分分析比较ARDS与非ARDS患者的代谢差异,并建立偏最小二乘判别分析(PLS-DA)模型识别ARDS,在另一组26例同病患者(验证集)中测试。结果显示,血清葡萄糖、丙氨酸、谷氨酰胺、甲基组氨酸和脂肪酸浓度降低,苯丙氨酸和甲基胍浓度升高可区分ARDS与非ARDS患者。PLS-DA模型在验证集中识别ARDS的成功率为92%(敏感性100%,特异性91%),分类函数与SOFA评分(R=0.74,P<0.0001)和PaO2/FiO2比值(R=0.41,P=0.03)有良好相关性。结论认为血清代谢组学对识别H1N1流感肺炎患者的ARDS敏感且特异,未来需研究NMR光谱作为ARDS生物标志物的作用。
要点
- 在H1N1流感病毒肺炎患者中,血清葡萄糖、丙氨酸、谷氨酰胺、甲基组氨酸和脂肪酸浓度降低,苯丙氨酸和甲基胍浓度升高,可区分ARDS与非ARDS。
- 基于NMR的PLS-DA模型在26例验证集中识别ARDS成功率92%(敏感性100%,特异性91%)。
- 分类函数与SOFA评分相关(R=0.74,P<0.0001),与PaO2/FiO2比值相关(R=0.41,P=0.03)。
- 作者结论:血清代谢组学对识别H1N1流感病毒肺炎患者的ARDS敏感且特异,未来需研究NMR光谱作为ARDS生物标志物的作用。
适用人群与场景
- 诊断为H1N1流感病毒肺炎的患者,推导集30例,验证集26例。
研究设计与关键结果
- 研究类型为代谢组学分析,推导集30例、验证集26例H1N1流感病毒肺炎患者,用NMR光谱分析血清,无监督主成分分析比较ARDS与非ARDS的代谢差异,并建立PLS-DA模型识别ARDS。
- 血清葡萄糖、丙氨酸、谷氨酰胺、甲基组氨酸和脂肪酸浓度降低,血清苯丙氨酸和甲基胍浓度升高,可区分ARDS患者与非ARDS患者。
- PLS-DA模型在验证集中识别ARDS的成功率为92%,敏感性100%,特异性91%。
- 分类函数与SOFA评分相关(R=0.74,P<0.0001),与PaO2/FiO2比值相关(R=0.41,P=0.03)。
证据类型、等级与局限
- 证据类型:代谢组学分析研究(推导集与验证集)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血清代谢组学对识别H1N1流感病毒肺炎患者的ARDS敏感且特异;未来需研究NMR光谱作为ARDS生物标志物的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The integrated analysis of changes in the metabolic profile could be critical for the discovery of biomarkers of lung injury, and also for generating new pathophysiological hypotheses and designing novel therapeutic targets for the acute respiratory distress syndrome (ARDS). This study aimed at developing a nuclear magnetic resonance (NMR)-based approach for the identification of the metabolomic profile of ARDS in patients with H1N1 influenza virus pneumonia.
METHODS: Serum samples from 30 patients (derivation set) diagnosed of H1N1 influenza virus pneumonia were analyzed by unsupervised principal component analysis to identify metabolic differences between patients with and without ARDS by NMR spectroscopy. A predictive model of partial least squares discriminant analysis (PLS-DA) was developed for the identification of ARDS. PLS-DA was trained with the derivation set and tested in another set of samples from 26 patients also diagnosed of H1N1 influenza virus pneumonia (validation set).
RESULTS: Decreased serum glucose, alanine, glutamine, methylhistidine and fatty acids concentrations, and elevated serum phenylalanine and methylguanidine concentrations, discriminated patients with ARDS versus patients without ARDS. PLS-DA model successfully identified the presence of ARDS in the validation set with a success rate of 92% (sensitivity 100% and specificity 91%). The classification functions showed a good correlation with the Sequential Organ Failure Assessment score (R = 0.74, P < 0.0001) and the PaO2/FiO2 ratio (R = 0.41, P = 0.03).
CONCLUSIONS: The serum metabolomic profile is sensitive and specific to identify ARDS in patients with H1N1 influenza A pneumonia. Future studies are needed to determine the role of NMR spectroscopy as a biomarker of ARDS.
参考来源
- Izquierdo-Garcia JL, Nin N, Jimenez-Clemente J, et al. Metabolomic Profile of ARDS by Nuclear Magnetic Resonance Spectroscopy in Patients With H1N1 Influenza Virus Pneumonia. Shock. 2018. PMID: 29293175. doi:10.1097/SHK.0000000000001099
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。